ONO-4538 Phase II Rollover Study (ONO-4538-98)

Recruiting now · Phase 2

Conditions studied: Pan-tumor

In brief

This study is intended to confirm the long-term safety of ONO-4538 in pan-tumor participants being treated with ONO-4538 monotherapy or in Combination with Other Therapies in clinical trials.

Key facts

Study ID

NCT04566380

Run by

Ono Pharmaceutical Co., Ltd.

People needed

59

Starts

2020-09-10

Expected to finish

2026-12-31

Last updated by the study team

2025-06-03

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant who is being treated with ONO-4538 as monotherapy or in Combination with Other Therapies in clinical trials
• Participant who is eligible for ONO-4538 monotherapy or in combination with other therapies as per the clinical trials, and/or investigator-assessed clinical benefit

You may not qualify if…

• Participant judged to be incapable of providing consent for reasons such as concurrent dementia
• Participant judged by the investigator to be inappropriate as participants of this study

Where it is running

• Taoyuan Clinical Site1 — Taoyuan, Taiwan (enrolling)
• Tainan Clinical Site2 — Tainan, Taiwan (enrolling)
• Taipei Clinical Site1 — Taipei, Taiwan (enrolling)
• Taipei Clinical Site2 — Taipei, Taiwan (enrolling)
• Chiba Clinical Site1 — Kashiwa, Chiba, Japan (enrolling)
• Fukuoka Clinical Site1 — Kurume, Fukuoka, Japan (enrolling)
• Hokkaido Clinical Site1 — Sapporo, Hokkaido, Japan (enrolling)
• Hyogo Clinical Site1 — Akashi, Hyōgo, Japan (enrolling)
• Kanagawa Clinical Site1 — Yokohama, Kanagawa, Japan (enrolling)
• Oita Clinical Site1 — Yufu, Oita Prefecture, Japan (enrolling)
• Osaka Clinical Site1 — Suita, Osaka, Japan (enrolling)
• Osaka Clinical Site3 — Takatsuki, Osaka, Japan (enrolling)
• Saitama Clinical Site1 — Hidaka, Saitama, Japan (enrolling)
• Saitama Clinical Site2 — Kitaadachi-gun, Saitama, Japan (enrolling)
• Tokyo Clinical Site3 — Bunkyo-ku, Tokyo, Japan (enrolling)
• Tokyo Clinical Site2 — Chuo-ku, Tokyo, Japan (enrolling)
• Tokyo Clinical Site1 — Koto-ku, Tokyo, Japan (enrolling)
• Tokyo Clinical Site4 — Shinjuku-ku, Tokyo, Japan (enrolling)
• Chiba Clinical Site2 — Chiba, Japan (enrolling)
• Fukuoka Clinical Site2 — Fukuoka, Japan (enrolling)
• Fukuoka Clinical Site3 — Fukuoka, Japan (enrolling)
• Hiroshima Clinical Site1 — Hiroshima, Japan (enrolling)
• Kyoto Clinical Site1 — Kyoto, Japan (enrolling)
• Okayama Clinical Site1 — Okayama, Japan (enrolling)
• Osaka Clinical Site2 — Osaka, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.